177 related articles for article (PubMed ID: 20509178)
1. Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation.
Buxton AE; Ellison KE; Lorvidhaya P; Ziv O
J Cardiovasc Pharmacol; 2010 May; 55(5):450-5. PubMed ID: 20509178
[TBL] [Abstract][Full Text] [Related]
2. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
Saba S
Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
[TBL] [Abstract][Full Text] [Related]
3. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
4. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
Buxton AE; Lee KL; Hafley GE; Pires LA; Fisher JD; Gold MR; Josephson ME; Lehmann MH; Prystowsky EN;
J Am Coll Cardiol; 2007 Sep; 50(12):1150-7. PubMed ID: 17868806
[TBL] [Abstract][Full Text] [Related]
5. [Risk stratification and prevention of sudden death in patients with heart failure].
Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
[TBL] [Abstract][Full Text] [Related]
6. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
8. Implanted cardioverter defibrillators for the prevention of sudden death.
Dorian P; Talajic M; Tang A
Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
[TBL] [Abstract][Full Text] [Related]
9. [Arrhythmia risk stratification in patients with heart failure. Foreword].
Opasich C; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
12. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
14. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
Kamath GS; Mittal S; Sherrid MV
Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
[TBL] [Abstract][Full Text] [Related]
15. Sudden death prophylaxis in heart failure.
Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
Grimm W; Alter P; Maisch B
Herz; 2004 May; 29(3):348-52. PubMed ID: 15167963
[TBL] [Abstract][Full Text] [Related]
17. Identifying the high risk patient with coronary artery disease--is ejection fraction all you need?
Buxton AE
J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S25-7. PubMed ID: 16138881
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
19. Role of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy.
Scott PA; Roberts PR
Postgrad Med J; 2010 Feb; 86(1012):116-22. PubMed ID: 20145061
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
Santangeli P; Dello Russo A; Casella M; Pelargonio G; Di Biase L; Natale A
Intern Med J; 2011 Jan; 41(1a):55-60. PubMed ID: 21265961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
